| Gene symbol | tk |
| GTO ID | GTC1800 |
| Trial ID | NCT03313596 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Adv-HSV-tk |
| Phase | Phase3 |
| Recruitment status | Unknown |
| Title | Treatment of Severe Combined Immunodeficiency Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency With Autologous Lymphocytes of CD34+ Cells Transduced With a Human ADA Gene: A Natural History Study |
| Year | 2017 |
| Country | China |
| Company sponsor | Huazhong University of Science and Technology |
| Other ID(s) | LT-03 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||
|
|||||||